Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the kidney (HP:0000077)help
Parent Node:
expand
Abnormal renal morphology (HP:0012210)help
..Starting node
..expand
Nephrolithiasis (HP:0000787)help
Term ID: 787
Name: Nephrolithiasis
Synonym: Kidney stones; Renal calculi; Renal stones
Definition: The presence of calculi (stones) in the kidneys.
Comments:
Reference: HP:0000787
Genes and Diseases:
 
       Child Nodes:
........expandUric acid nephrolithiasis (HP:0000791) help
................... HP:0008651 Uric acid urolithiasis independent of gout
........expandXanthine nephrolithiasis (HP:0000804) help
........expandCalcium nephrolithiasis (HP:0004724) help
................... HP:0008672 Calcium oxalate nephrolithiasis
................... HP:0012580 Calcium phosphate nephrolithiasis
........expandStruvite nephrolithiasis (HP:0030035) help

 Sister Nodes: 
..expandAbnormal localization of kidney (HP:0100542) help
..expandAbnormal nephron morphology (HP:0012575) help
..expandAbnormal renal artery morphology (HP:0008776) help
..expandAbnormal renal calyx morphology (HP:0011130) help
..expandAbnormal renal collecting system morphology (HP:0004742) help
..expandAbnormal renal cortex morphology (HP:0011035) help
..expandAbnormal renal medulla morphology (HP:0100957) help
..expandAbnormal renal pelvis morphology (HP:0010944) help
..expandDecreased renal parenchymal thickness (HP:0025327) help
..expandEnlarged kidney (HP:0000105) help
..expandHyperechogenic kidneys (HP:0004719) help
..expandNephrocalcinosis (HP:0000121) help
..expandNephrogenic rest (HP:0100880) help
..expandNephrosclerosis (HP:0009741) help
..expandPerinephric fluid collection (HP:0031226) help
..expandPerirenal hematoma (HP:0030171) help
..expandRenal amyloidosis (HP:0001917) help
..expandRenal atrophy (HP:0012585) help
..expandRenal cyst (HP:0000107) help
..expandRenal duplication (HP:0000075) help
..expandRenal dysplasia (HP:0000110) help
..expandRenal fibrosis (HP:0030760) help
..expandRenal hypoplasia/aplasia (HP:0008678) help
..expandRenal malrotation (HP:0004712) help
..expandRenal steatosis (HP:0000799) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000787HP:0000787Nephrolithiasis0ACVRL1 CL E G H94175ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional178
HP:0000787HP:0000787Nephrolithiasis0ADAMTSL1 CL E G H9294914632ORPHA:521445Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndromeHP:0040282 - Frequent
HP:0000787HP:0000787Nephrolithiasis0ADCY10 CL E G H5581121285OMIM:143870Hypercalciuria, absorptive, susceptibility to5
HP:0000787HP:0000787Nephrolithiasis0ADCY10 CL E G H5581121285ORPHA:2197Idiopathic hypercalciuria5
HP:0000787HP:0000787Nephrolithiasis0AGPAT2 CL E G H10555325OMIM:608594Lipodystrophy, congenital generalized, type 1.85
HP:0000787HP:0000787Nephrolithiasis0AGXT CL E G H189341OMIM:259900Hyperoxaluria, primary, type I260
HP:0000787HP:0000787Nephrolithiasis0AGXT CL E G H189341ORPHA:93598Primary hyperoxaluria type 1HP:0040281 - Very frequent260
HP:0000787HP:0000787Nephrolithiasis0AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.95
HP:0000787HP:0000787Nephrolithiasis0ALG5 CL E G H2988020266ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0ALG9 CL E G H7979615672ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040283 - Occasional93
HP:0000787HP:0000787Nephrolithiasis0ANTXR1 CL E G H8416821014ORPHA:2067GAPO syndromeHP:0040283 - Occasional8
HP:0000787HP:0000787Nephrolithiasis0AP2S1 CL E G H1175565OMIM:600740Hypocalciuric hypercalcemia, familial, type IIIHP:0040283 - Occasional6
HP:0000787HP:0000787Nephrolithiasis0APRT CL E G H353626OMIM:614723Adenine phosphoribosyltransferase deficiency.19
HP:0000787HP:0000787Nephrolithiasis0APRT CL E G H353626ORPHA:976Adenine phosphoribosyltransferase deficiencyHP:0040282 - Frequent19
HP:0000787HP:0000787Nephrolithiasis0ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasiaHP:0040282 - Frequent7
HP:0000787HP:0000787Nephrolithiasis0ARSK CL E G H15364225239OMIM:619698MUCOPOLYSACCHARIDOSIS, TYPE X; MPS10
HP:0000787HP:0000787Nephrolithiasis0ATP6V1B1 CL E G H525853OMIM:267300Renal tubular acidosis, distal, with progressive nerve deafness.67
HP:0000787HP:0000787Nephrolithiasis0ATP7B CL E G H540870OMIM:277900Wilson disease.315
HP:0000787HP:0000787Nephrolithiasis0BAZ1B CL E G H9031961ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0BCL7B CL E G H92751005ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0BICC1 CL E G H8011419351ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040283 - Occasional5
HP:0000787HP:0000787Nephrolithiasis0BSCL2 CL E G H2658015832OMIM:269700Lipodystrophy, congenital generalized, type 2.105
HP:0000787HP:0000787Nephrolithiasis0BTNL2 CL E G H562441142ORPHA:797SarcoidosisHP:0040283 - Occasional1
HP:0000787HP:0000787Nephrolithiasis0BUD23 CL E G H11404916405ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0CA2 CL E G H7601373ORPHA:2785Osteopetrosis with renal tubular acidosis29
HP:0000787HP:0000787Nephrolithiasis0CACNA1D CL E G H7761391OMIM:615474Primary aldosteronism, seizures, and neurologic abnormalitiesHP:0040283 - Occasional51
HP:0000787HP:0000787Nephrolithiasis0CACNA1D CL E G H7761391ORPHA:369929Primary hyperaldosteronism-seizures-neurological abnormalities syndromeHP:0040283 - Occasional51
HP:0000787HP:0000787Nephrolithiasis0CAMKMT CL E G H7982326276ORPHA:1636932p21 microdeletion syndromeHP:0040281 - Very frequent1
HP:0000787HP:0000787Nephrolithiasis0CASR CL E G H8461514OMIM:601198Hypocalcemia, autosomal dominant 1272
HP:0000787HP:0000787Nephrolithiasis0CASR CL E G H8461514OMIM:145980Hypocalciuric hypercalcemia, familial, type I.272
HP:0000787HP:0000787Nephrolithiasis0CDC73 CL E G H7957716783OMIM:145001Hyperparathyroidism 2.169
HP:0000787HP:0000787Nephrolithiasis0CDC73 CL E G H7957716783ORPHA:99880Hyperparathyroidism-jaw tumor syndromeHP:0040282 - Frequent169
HP:0000787HP:0000787Nephrolithiasis0CDC73 CL E G H7957716783ORPHA:143Parathyroid carcinomaHP:0040282 - Frequent169
HP:0000787HP:0000787Nephrolithiasis0CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional2
HP:0000787HP:0000787Nephrolithiasis0CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional102
HP:0000787HP:0000787Nephrolithiasis0CDKN1C CL E G H10281786OMIM:130650Beckwith-Wiedemann syndrome.114
HP:0000787HP:0000787Nephrolithiasis0CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional1
HP:0000787HP:0000787Nephrolithiasis0CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0CEACAM3 CL E G H10841815ORPHA:586Cystic fibrosis
HP:0000787HP:0000787Nephrolithiasis0CEACAM6 CL E G H46801818ORPHA:586Cystic fibrosis1
HP:0000787HP:0000787Nephrolithiasis0CFTR CL E G H10801884ORPHA:586Cystic fibrosis1371
HP:0000787HP:0000787Nephrolithiasis0CHKA CL E G H11191937OMIM:620023
HP:0000787HP:0000787Nephrolithiasis0CHST14 CL E G H11318924464ORPHA:2953Musculocontractural Ehlers-Danlos syndromeHP:0040283 - Occasional27
HP:0000787HP:0000787Nephrolithiasis0CLCA4 CL E G H228022018ORPHA:586Cystic fibrosis
HP:0000787HP:0000787Nephrolithiasis0CLCN5 CL E G H11842023OMIM:300009Dent disease 1112
HP:0000787HP:0000787Nephrolithiasis0CLCN5 CL E G H11842023OMIM:300554Hypophosphatemic rickets, X-linked recessive.112
HP:0000787HP:0000787Nephrolithiasis0CLCN5 CL E G H11842023OMIM:310468Nephrolithiasis, type I.112
HP:0000787HP:0000787Nephrolithiasis0CLDN10 CL E G H90712033OMIM:617671Helix syndrome3
HP:0000787HP:0000787Nephrolithiasis0CLDN16 CL E G H106862037OMIM:248250Hypomagnesemia 3, renal.58
HP:0000787HP:0000787Nephrolithiasis0CLDN19 CL E G H1494612040ORPHA:2196Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvementHP:0040281 - Very frequent42
HP:0000787HP:0000787Nephrolithiasis0CLDN19 CL E G H1494612040OMIM:248190Hypomagnesemia 5, renal, with or without ocular involvement.42
HP:0000787HP:0000787Nephrolithiasis0CLDN2 CL E G H90752041OMIM:301060AZOOSPERMIA, OBSTRUCTIVE, WITH NEPHROLITHIASIS; OAZON2
HP:0000787HP:0000787Nephrolithiasis0CLIP2 CL E G H74612586ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0COQ6 CL E G H5100420233OMIM:614650Coenzyme Q10 deficiency, primary, 639
HP:0000787HP:0000787Nephrolithiasis0CREBBP CL E G H13872348ORPHA:353281Rubinstein-Taybi syndrome due to 16p13.3 microdeletionHP:0040283 - Occasional291
HP:0000787HP:0000787Nephrolithiasis0CREBBP CL E G H13872348ORPHA:353277Rubinstein-Taybi syndrome due to CREBBP mutationsHP:0040283 - Occasional291
HP:0000787HP:0000787Nephrolithiasis0CTH CL E G H14912501ORPHA:212CystathioninuriaHP:0040283 - Occasional38
HP:0000787HP:0000787Nephrolithiasis0CTNS CL E G H14972518OMIM:219800Cystinosis, nephropathic.178
HP:0000787HP:0000787Nephrolithiasis0CYP24A1 CL E G H15912602OMIM:143880Hypercalcemia, infantile, 1HP:0040283 - Occasional73
HP:0000787HP:0000787Nephrolithiasis0DCTN4 CL E G H5116415518ORPHA:586Cystic fibrosis
HP:0000787HP:0000787Nephrolithiasis0DNAJB11 CL E G H5172614889ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0DNAJC30 CL E G H8427716410ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0DSE CL E G H2994021144ORPHA:2953Musculocontractural Ehlers-Danlos syndromeHP:0040283 - Occasional13
HP:0000787HP:0000787Nephrolithiasis0EDNRA CL E G H19093179ORPHA:586Cystic fibrosis3
HP:0000787HP:0000787Nephrolithiasis0EIF4H CL E G H745812741ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0ELN CL E G H20063327ORPHA:904Williams syndromeHP:0040283 - Occasional172
HP:0000787HP:0000787Nephrolithiasis0ENG CL E G H20223349ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional186
HP:0000787HP:0000787Nephrolithiasis0EP300 CL E G H20333373ORPHA:353284Rubinstein-Taybi syndrome due to EP300 haploinsufficiencyHP:0040283 - Occasional250
HP:0000787HP:0000787Nephrolithiasis0FBN1 CL E G H22003603ORPHA:2833Stiff skin syndromeHP:0040283 - Occasional1361
HP:0000787HP:0000787Nephrolithiasis0FKBP6 CL E G H84683722ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0G6PC1 CL E G H25384056OMIM:232200Glycogen storage disease ia.
HP:0000787HP:0000787Nephrolithiasis0GANAB CL E G H231934138ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040283 - Occasional6
HP:0000787HP:0000787Nephrolithiasis0GCLC CL E G H27294311ORPHA:586Cystic fibrosis2
HP:0000787HP:0000787Nephrolithiasis0GCM2 CL E G H92474198OMIM:617343Hyperparathyroidism 4HP:0040283 - Occasional51
HP:0000787HP:0000787Nephrolithiasis0GDF2 CL E G H26584217ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional8
HP:0000787HP:0000787Nephrolithiasis0GNA11 CL E G H27674379OMIM:145981Hypocalciuric hypercalcemia, familial, type IIHP:0040283 - Occasional16
HP:0000787HP:0000787Nephrolithiasis0GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasiaHP:0040282 - Frequent101
HP:0000787HP:0000787Nephrolithiasis0GRHPR CL E G H93804570OMIM:260000Hyperoxaluria, primary, type II70
HP:0000787HP:0000787Nephrolithiasis0GRHPR CL E G H93804570ORPHA:93599Primary hyperoxaluria type 2HP:0040281 - Very frequent70
HP:0000787HP:0000787Nephrolithiasis0GSTM3 CL E G H29474635ORPHA:586Cystic fibrosis1
HP:0000787HP:0000787Nephrolithiasis0GTF2I CL E G H29694659ORPHA:904Williams syndromeHP:0040283 - Occasional1
HP:0000787HP:0000787Nephrolithiasis0GTF2IRD1 CL E G H95694661ORPHA:904Williams syndromeHP:0040283 - Occasional1
HP:0000787HP:0000787Nephrolithiasis0GTF2IRD2 CL E G H8416330775ORPHA:904Williams syndromeHP:0040283 - Occasional1
HP:0000787HP:0000787Nephrolithiasis0H19-ICR CL E G H105259599OMIM:130650Beckwith-Wiedemann syndrome.
HP:0000787HP:0000787Nephrolithiasis0HFE CL E G H30774886ORPHA:586Cystic fibrosis38
HP:0000787HP:0000787Nephrolithiasis0HGD CL E G H30814892OMIM:203500Alkaptonuria77
HP:0000787HP:0000787Nephrolithiasis0HGD CL E G H30814892ORPHA:56AlkaptonuriaHP:0040282 - Frequent77
HP:0000787HP:0000787Nephrolithiasis0HLA-DRB1 CL E G H31234948ORPHA:797SarcoidosisHP:0040283 - Occasional2
HP:0000787HP:0000787Nephrolithiasis0HMOX1 CL E G H31625013ORPHA:586Cystic fibrosis3
HP:0000787HP:0000787Nephrolithiasis0HNF1B CL E G H692811630ORPHA:1309Medullary sponge kidneyHP:0040281 - Very frequent90
HP:0000787HP:0000787Nephrolithiasis0HNF1B CL E G H692811630OMIM:137920Renal cysts and diabetes syndrome.90
HP:0000787HP:0000787Nephrolithiasis0HOGA1 CL E G H11281725155OMIM:613616HYPEROXALURIA, PRIMARY, TYPE III; HP383
HP:0000787HP:0000787Nephrolithiasis0HOGA1 CL E G H11281725155ORPHA:93600Primary hyperoxaluria type 383
HP:0000787HP:0000787Nephrolithiasis0HPRT1 CL E G H32515157OMIM:300323Gout, hprt-related.76
HP:0000787HP:0000787Nephrolithiasis0HPRT1 CL E G H32515157ORPHA:79233Hypoxanthine guanine phosphoribosyltransferase partial deficiency76
HP:0000787HP:0000787Nephrolithiasis0HPRT1 CL E G H32515157OMIM:300322Lesch-Nyhan syndrome.76
HP:0000787HP:0000787Nephrolithiasis0HSPG2 CL E G H33395273ORPHA:800Schwartz-Jampel syndromeHP:0040283 - Occasional345
HP:0000787HP:0000787Nephrolithiasis0IFT140 CL E G H974229077ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040283 - Occasional148
HP:0000787HP:0000787Nephrolithiasis0IGF2 CL E G H34815466OMIM:130650Beckwith-Wiedemann syndrome.9
HP:0000787HP:0000787Nephrolithiasis0KCNH1 CL E G H37566250OMIM:135500Zimmermann-Laband syndrome 1HP:0040283 - Occasional13
HP:0000787HP:0000787Nephrolithiasis0KCNN4 CL E G H37836293ORPHA:586Cystic fibrosis3
HP:0000787HP:0000787Nephrolithiasis0KCNQ1 CL E G H37846294OMIM:130650Beckwith-Wiedemann syndrome.730
HP:0000787HP:0000787Nephrolithiasis0KCNQ1OT1 CL E G H109846295OMIM:130650Beckwith-Wiedemann syndrome.1
HP:0000787HP:0000787Nephrolithiasis0KRT17 CL E G H38726427ORPHA:841SebocystomatosisHP:0040283 - Occasional23
HP:0000787HP:0000787Nephrolithiasis0LIMK1 CL E G H39846613ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional462
HP:0000787HP:0000787Nephrolithiasis0METTL27 CL E G H15536819068ORPHA:904Williams syndromeHP:0040283 - Occasional1
HP:0000787HP:0000787Nephrolithiasis0MGME1 CL E G H9266716205ORPHA:352447Progressive external ophthalmoplegia-myopathy-emaciation syndromeHP:0040283 - Occasional11
HP:0000787HP:0000787Nephrolithiasis0MIF CL E G H42827097ORPHA:586Cystic fibrosis1
HP:0000787HP:0000787Nephrolithiasis0MLXIPL CL E G H5108512744ORPHA:904Williams syndromeHP:0040283 - Occasional1
HP:0000787HP:0000787Nephrolithiasis0MOCOS CL E G H5503418234OMIM:603592Xanthinuria, type IIHP:0040283 - Occasional4
HP:0000787HP:0000787Nephrolithiasis0MOCS1 CL E G H43377190OMIM:252150Molybdenum cofactor deficiency, complementation group A96
HP:0000787HP:0000787Nephrolithiasis0MOCS2 CL E G H43387193OMIM:252160Molybdenum cofactor deficiency, complementation group B26
HP:0000787HP:0000787Nephrolithiasis0MYL9 CL E G H1039815754OMIM:619365MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 4; MMIHS4
HP:0000787HP:0000787Nephrolithiasis0NCF1 CL E G H6533617660ORPHA:904Williams syndromeHP:0040283 - Occasional13
HP:0000787HP:0000787Nephrolithiasis0NHERF1 CL E G H936811075OMIM:612287Nephrolithiasis/osteoporosis, hypophosphatemic, 2.
HP:0000787HP:0000787Nephrolithiasis0NOD2 CL E G H641275331OMIM:617321YAO SYNDROME; YAOS187
HP:0000787HP:0000787Nephrolithiasis0OCRL CL E G H49528108ORPHA:534Oculocerebrorenal syndrome of LoweHP:0040283 - Occasional88
HP:0000787HP:0000787Nephrolithiasis0OPLAH CL E G H268738149OMIM:2600055-@oxoprolinase deficiency5
HP:0000787HP:0000787Nephrolithiasis0PAX2 CL E G H50768616OMIM:120330Papillorenal syndromeHP:0040283 - Occasional39
HP:0000787HP:0000787Nephrolithiasis0PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0000787HP:0000787Nephrolithiasis0PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0000787HP:0000787Nephrolithiasis0PIDD1 CL E G H5536716491OMIM:619827INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 75, WITH NEUROPSYCHIATRIC FEATURES AND VARIANT LISSENCEPHALY; MRT75
HP:0000787HP:0000787Nephrolithiasis0PKD1 CL E G H53109008ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040283 - Occasional342
HP:0000787HP:0000787Nephrolithiasis0PKD2 CL E G H53119009ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040283 - Occasional106
HP:0000787HP:0000787Nephrolithiasis0PLCD1 CL E G H53339060ORPHA:2387Leukonychia totalisHP:0040281 - Very frequent5
HP:0000787HP:0000787Nephrolithiasis0PLG CL E G H53409071ORPHA:722HypoplasminogenemiaHP:0040283 - Occasional11
HP:0000787HP:0000787Nephrolithiasis0PLG CL E G H53409071OMIM:217090Plasminogen deficiency, type iligneous conjunctivitis, included.11
HP:0000787HP:0000787Nephrolithiasis0PPM1B CL E G H54959276ORPHA:1636932p21 microdeletion syndromeHP:0040281 - Very frequent
HP:0000787HP:0000787Nephrolithiasis0PREPL CL E G H958130228ORPHA:1636932p21 microdeletion syndromeHP:0040281 - Very frequent7
HP:0000787HP:0000787Nephrolithiasis0PREPL CL E G H958130228ORPHA:163690Hypotonia-cystinuria syndromeHP:0040281 - Very frequent7
HP:0000787HP:0000787Nephrolithiasis0PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0000787HP:0000787Nephrolithiasis0PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0000787HP:0000787Nephrolithiasis0PRPS1 CL E G H56319462ORPHA:411536Mild phosphoribosylpyrophosphate synthetase superactivity49
HP:0000787HP:0000787Nephrolithiasis0PRPS1 CL E G H56319462OMIM:300661Phosphoribosylpyrophosphate synthetase superactivity49
HP:0000787HP:0000787Nephrolithiasis0PRPS1 CL E G H56319462ORPHA:411543Severe phosphoribosylpyrophosphate synthetase superactivity49
HP:0000787HP:0000787Nephrolithiasis0RFC2 CL E G H59829970ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0ROR2 CL E G H492010257OMIM:268310Robinow syndrome, autosomal recessive120
HP:0000787HP:0000787Nephrolithiasis0SERPINA1 CL E G H52658941ORPHA:586Cystic fibrosis131
HP:0000787HP:0000787Nephrolithiasis0SERPINH1 CL E G H8711546OMIM:613848Osteogenesis imperfecta, type X.52
HP:0000787HP:0000787Nephrolithiasis0SETBP1 CL E G H2604015573ORPHA:798Schinzel-Giedion syndromeHP:0040284 - Very rare143
HP:0000787HP:0000787Nephrolithiasis0SI CL E G H647610856OMIM:222900Sucrase-isomaltase deficiency, congenital.98
HP:0000787HP:0000787Nephrolithiasis0SLC11A1 CL E G H655610907ORPHA:586Cystic fibrosis2
HP:0000787HP:0000787Nephrolithiasis0SLC1A1 CL E G H650510939OMIM:222730Dicarboxylicamino aciduria71
HP:0000787HP:0000787Nephrolithiasis0SLC22A12 CL E G H11608517989ORPHA:94088Hereditary renal hypouricemia56
HP:0000787HP:0000787Nephrolithiasis0SLC22A12 CL E G H11608517989OMIM:220150Hypouricemia, renal, 156
HP:0000787HP:0000787Nephrolithiasis0SLC26A1 CL E G H1086110993OMIM:167030Nephrolithiasis, calcium oxalate24
HP:0000787HP:0000787Nephrolithiasis0SLC26A9 CL E G H11501914469ORPHA:586Cystic fibrosis5
HP:0000787HP:0000787Nephrolithiasis0SLC2A9 CL E G H5660613446ORPHA:94088Hereditary renal hypouricemia57
HP:0000787HP:0000787Nephrolithiasis0SLC2A9 CL E G H5660613446OMIM:612076Hypouricemia, renal, 2HP:0040283 - Occasional57
HP:0000787HP:0000787Nephrolithiasis0SLC34A1 CL E G H656911019ORPHA:157215Hereditary hypophosphatemic rickets with hypercalciuriaHP:0040282 - Frequent47
HP:0000787HP:0000787Nephrolithiasis0SLC34A1 CL E G H656911019OMIM:612286Nephrolithiasis/osteoporosis, hypophosphatemic, 1.47
HP:0000787HP:0000787Nephrolithiasis0SLC34A2 CL E G H1056811020ORPHA:60025Pulmonary alveolar microlithiasis7
HP:0000787HP:0000787Nephrolithiasis0SLC34A3 CL E G H14268020305ORPHA:157215Hereditary hypophosphatemic rickets with hypercalciuriaHP:0040282 - Frequent52
HP:0000787HP:0000787Nephrolithiasis0SLC34A3 CL E G H14268020305OMIM:241530Hypophosphatemic rickets with hypercalciuria, hereditary52
HP:0000787HP:0000787Nephrolithiasis0SLC36A2 CL E G H15320118762OMIM:138500Glycinuria with or without oxalate urolithiasis2
HP:0000787HP:0000787Nephrolithiasis0SLC37A4 CL E G H25424061ORPHA:79259Glycogen storage disease due to glucose-6-phosphatase deficiency type IbHP:0040283 - Occasional110
HP:0000787HP:0000787Nephrolithiasis0SLC37A4 CL E G H25424061OMIM:232220Glycogen storage disease ib.110
HP:0000787HP:0000787Nephrolithiasis0SLC3A1 CL E G H651911025ORPHA:1636932p21 microdeletion syndromeHP:0040281 - Very frequent55
HP:0000787HP:0000787Nephrolithiasis0SLC3A1 CL E G H651911025OMIM:220100CYSTINURIA.55
HP:0000787HP:0000787Nephrolithiasis0SLC3A1 CL E G H651911025ORPHA:163690Hypotonia-cystinuria syndromeHP:0040281 - Very frequent55
HP:0000787HP:0000787Nephrolithiasis0SLC4A1 CL E G H652111027OMIM:179800Renal tubular acidosis, distal, autosomal dominant109
HP:0000787HP:0000787Nephrolithiasis0SLC5A1 CL E G H652311036ORPHA:35710Glucose-galactose malabsorptionHP:0040283 - Occasional74
HP:0000787HP:0000787Nephrolithiasis0SLC6A14 CL E G H1125411047ORPHA:586Cystic fibrosis
HP:0000787HP:0000787Nephrolithiasis0SLC6A19 CL E G H34002427960OMIM:138500Glycinuria with or without oxalate urolithiasis12
HP:0000787HP:0000787Nephrolithiasis0SLC6A20 CL E G H5471630927OMIM:138500Glycinuria with or without oxalate urolithiasis96
HP:0000787HP:0000787Nephrolithiasis0SLC7A9 CL E G H1113611067OMIM:220100CYSTINURIA.58
HP:0000787HP:0000787Nephrolithiasis0SLC9A3 CL E G H655011073ORPHA:586Cystic fibrosis7
HP:0000787HP:0000787Nephrolithiasis0SMAD4 CL E G H40896770ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional504
HP:0000787HP:0000787Nephrolithiasis0SPRED1 CL E G H16174220249ORPHA:137605Legius syndrome136
HP:0000787HP:0000787Nephrolithiasis0STX1A CL E G H680411433ORPHA:586Cystic fibrosis
HP:0000787HP:0000787Nephrolithiasis0STX1A CL E G H680411433ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0TBL2 CL E G H2660811586ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0TGFB1 CL E G H704011766ORPHA:586Cystic fibrosis13
HP:0000787HP:0000787Nephrolithiasis0TMEM270 CL E G H13588623018ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.7
HP:0000787HP:0000787Nephrolithiasis0VDR CL E G H742112679ORPHA:93160Hypocalcemic vitamin D-resistant ricketsHP:0040282 - Frequent104
HP:0000787HP:0000787Nephrolithiasis0VPS37D CL E G H15538218287ORPHA:904Williams syndromeHP:0040283 - Occasional
HP:0000787HP:0000787Nephrolithiasis0XDH CL E G H749812805OMIM:278300Xanthinuria, type I79
HP:0000787HP:0033591Staghorn calculus1 CL E G H
HP:0000787HP:0030035Struvite nephrolithiasis1 CL E G H
HP:0000787HP:0004724Calcium nephrolithiasis1ADCY10 CL E G H5581121285OMIM:143870Hypercalciuria, absorptive, susceptibility to5
HP:0000787HP:0004724Calcium nephrolithiasis1ADCY10 CL E G H5581121285ORPHA:2197Idiopathic hypercalciuria5
HP:0000787HP:0004724Calcium nephrolithiasis1AGXT CL E G H189341OMIM:259900Hyperoxaluria, primary, type I260
HP:0000787HP:0000791Uric acid nephrolithiasis1APRT CL E G H353626ORPHA:976Adenine phosphoribosyltransferase deficiencyHP:0040283 - Occasional19
HP:0000787HP:0004724Calcium nephrolithiasis1GRHPR CL E G H93804570OMIM:260000Hyperoxaluria, primary, type II70
HP:0000787HP:0004724Calcium nephrolithiasis1HOGA1 CL E G H11281725155OMIM:613616HYPEROXALURIA, PRIMARY, TYPE III; HP383
HP:0000787HP:0004724Calcium nephrolithiasis1HOGA1 CL E G H11281725155ORPHA:93600Primary hyperoxaluria type 383
HP:0000787HP:0000791Uric acid nephrolithiasis1HPRT1 CL E G H32515157ORPHA:79233Hypoxanthine guanine phosphoribosyltransferase partial deficiencyHP:0040283 - Occasional76
HP:0000787HP:0000804Xanthine nephrolithiasis1MOCS1 CL E G H43377190OMIM:252150Molybdenum cofactor deficiency, complementation group A.96
HP:0000787HP:0000804Xanthine nephrolithiasis1MOCS2 CL E G H43387193OMIM:252160Molybdenum cofactor deficiency, complementation group B.26
HP:0000787HP:0004724Calcium nephrolithiasis1OPLAH CL E G H268738149OMIM:2600055-@oxoprolinase deficiency5
HP:0000787HP:0000791Uric acid nephrolithiasis1PRPS1 CL E G H56319462ORPHA:411536Mild phosphoribosylpyrophosphate synthetase superactivityHP:0040282 - Frequent49
HP:0000787HP:0000791Uric acid nephrolithiasis1PRPS1 CL E G H56319462OMIM:300661Phosphoribosylpyrophosphate synthetase superactivity.49
HP:0000787HP:0000791Uric acid nephrolithiasis1PRPS1 CL E G H56319462ORPHA:411543Severe phosphoribosylpyrophosphate synthetase superactivityHP:0040281 - Very frequent49
HP:0000787HP:0000791Uric acid nephrolithiasis1SLC22A12 CL E G H11608517989ORPHA:94088Hereditary renal hypouricemia56
HP:0000787HP:0000791Uric acid nephrolithiasis1SLC22A12 CL E G H11608517989OMIM:220150Hypouricemia, renal, 1.56
HP:0000787HP:0004724Calcium nephrolithiasis1SLC26A1 CL E G H1086110993OMIM:167030Nephrolithiasis, calcium oxalate24
HP:0000787HP:0000791Uric acid nephrolithiasis1SLC2A9 CL E G H5660613446ORPHA:94088Hereditary renal hypouricemia57
HP:0000787HP:0004724Calcium nephrolithiasis1SLC34A2 CL E G H1056811020ORPHA:60025Pulmonary alveolar microlithiasisHP:0040284 - Very rare7
HP:0000787HP:0004724Calcium nephrolithiasis1SLC34A3 CL E G H14268020305OMIM:241530Hypophosphatemic rickets with hypercalciuria, hereditary.52
HP:0000787HP:0004724Calcium nephrolithiasis1SLC36A2 CL E G H15320118762OMIM:138500Glycinuria with or without oxalate urolithiasis2
HP:0000787HP:0004724Calcium nephrolithiasis1SLC6A19 CL E G H34002427960OMIM:138500Glycinuria with or without oxalate urolithiasis12
HP:0000787HP:0004724Calcium nephrolithiasis1SLC6A20 CL E G H5471630927OMIM:138500Glycinuria with or without oxalate urolithiasis96
HP:0000787HP:0000804Xanthine nephrolithiasis1XDH CL E G H749812805OMIM:278300Xanthinuria, type I.79
HP:0000787HP:0012580Calcium phosphate nephrolithiasis2 CL E G H
HP:0000787HP:0008672Calcium oxalate nephrolithiasis2ADCY10 CL E G H5581121285OMIM:143870Hypercalciuria, absorptive, susceptibility to.5
HP:0000787HP:0008672Calcium oxalate nephrolithiasis2ADCY10 CL E G H5581121285ORPHA:2197Idiopathic hypercalciuriaHP:0040282 - Frequent5
HP:0000787HP:0008672Calcium oxalate nephrolithiasis2AGXT CL E G H189341OMIM:259900Hyperoxaluria, primary, type I.260
HP:0000787HP:0008672Calcium oxalate nephrolithiasis2GRHPR CL E G H93804570OMIM:260000Hyperoxaluria, primary, type II.70
HP:0000787HP:0008672Calcium oxalate nephrolithiasis2HOGA1 CL E G H11281725155OMIM:613616HYPEROXALURIA, PRIMARY, TYPE III; HP383
HP:0000787HP:0008672Calcium oxalate nephrolithiasis2HOGA1 CL E G H11281725155ORPHA:93600Primary hyperoxaluria type 3HP:0040281 - Very frequent83
HP:0000787HP:0008672Calcium oxalate nephrolithiasis2OPLAH CL E G H268738149OMIM:2600055-@oxoprolinase deficiency.5
HP:0000787HP:0008651Uric acid urolithiasis independent of gout2SLC22A12 CL E G H11608517989ORPHA:94088Hereditary renal hypouricemiaHP:0040282 - Frequent56
HP:0000787HP:0008672Calcium oxalate nephrolithiasis2SLC26A1 CL E G H1086110993OMIM:167030Nephrolithiasis, calcium oxalate.24
HP:0000787HP:0008651Uric acid urolithiasis independent of gout2SLC2A9 CL E G H5660613446ORPHA:94088Hereditary renal hypouricemiaHP:0040282 - Frequent57
HP:0000787HP:0008672Calcium oxalate nephrolithiasis2SLC36A2 CL E G H15320118762OMIM:138500Glycinuria with or without oxalate urolithiasis.2
HP:0000787HP:0008672Calcium oxalate nephrolithiasis2SLC6A19 CL E G H34002427960OMIM:138500Glycinuria with or without oxalate urolithiasis.12
HP:0000787HP:0008672Calcium oxalate nephrolithiasis2SLC6A20 CL E G H5471630927OMIM:138500Glycinuria with or without oxalate urolithiasis.96


Genes (150) :ACVRL1 ADAMTSL1 ADCY10 AGPAT2 AGXT AIP ALG5 ALG9 ANTXR1 AP2S1 APRT ARMC5 ARSK ATP6V1B1 ATP7B BAZ1B BCL7B BICC1 BSCL2 BTNL2 BUD23 CA2 CACNA1D CAMKMT CASR CDC73 CDKN1A CDKN1B CDKN1C CDKN2B CDKN2C CEACAM3 CEACAM6 CFTR CHKA CHST14 CLCA4 CLCN5 CLDN10 CLDN16 CLDN19 CLDN2 CLIP2 COQ6 CREBBP CTH CTNS CYP24A1 DCTN4 DNAJB11 DNAJC30 DSE EDNRA EIF4H ELN ENG EP300 FBN1 FKBP6 G6PC1 GANAB GCLC GCM2 GDF2 GNA11 GNAS GRHPR GSTM3 GTF2I GTF2IRD1 GTF2IRD2 H19-ICR HFE HGD HLA-DRB1 HMOX1 HNF1B HOGA1 HPRT1 HSPG2 IFT140 IGF2 KCNH1 KCNN4 KCNQ1 KCNQ1OT1 KRT17 LIMK1 MEN1 METTL27 MGME1 MIF MLXIPL MOCOS MOCS1 MOCS2 MYL9 NCF1 NHERF1 NOD2 OCRL OPLAH PAX2 PDE11A PDE8B PIDD1 PKD1 PKD2 PLCD1 PLG PPM1B PREPL PRKACA PRKAR1A PRPS1 RFC2 ROR2 SERPINA1 SERPINH1 SETBP1 SI SLC11A1 SLC1A1 SLC22A12 SLC26A1 SLC26A9 SLC2A9 SLC34A1 SLC34A2 SLC34A3 SLC36A2 SLC37A4 SLC3A1 SLC4A1 SLC5A1 SLC6A14 SLC6A19 SLC6A20 SLC7A9 SLC9A3 SMAD4 SPRED1 STX1A TBL2 TGFB1 TMEM270 USP8 VDR VPS37D XDH

Diseases (108) :ORPHA:774 ORPHA:521445 OMIM:143870 ORPHA:2197 OMIM:608594 OMIM:259900 ORPHA:93598 OMIM:219090 ORPHA:730 ORPHA:2067 OMIM:600740 OMIM:614723 ORPHA:976 ORPHA:189427 OMIM:619698 OMIM:267300 OMIM:277900 ORPHA:904 OMIM:269700 ORPHA:797 ORPHA:2785 OMIM:615474 ORPHA:369929 ORPHA:163693 OMIM:601198 OMIM:145980 OMIM:145001 ORPHA:99880 ORPHA:143 ORPHA:652 OMIM:130650 ORPHA:586 OMIM:620023 ORPHA:2953 OMIM:300009 OMIM:300554 OMIM:310468 OMIM:617671 OMIM:248250 ORPHA:2196 OMIM:248190 OMIM:301060 OMIM:614650 ORPHA:353281 ORPHA:353277 ORPHA:212 OMIM:219800 OMIM:143880 ORPHA:353284 ORPHA:2833 OMIM:232200 OMIM:617343 OMIM:145981 OMIM:260000 ORPHA:93599 OMIM:203500 ORPHA:56 ORPHA:1309 OMIM:137920 OMIM:613616 ORPHA:93600 OMIM:300323 ORPHA:79233 OMIM:300322 ORPHA:800 OMIM:135500 ORPHA:841 ORPHA:352447 OMIM:603592 OMIM:252150 OMIM:252160 OMIM:619365 OMIM:612287 OMIM:617321 ORPHA:534 OMIM:260005 OMIM:120330 ORPHA:189439 OMIM:619827 ORPHA:2387 ORPHA:722 OMIM:217090 ORPHA:163690 ORPHA:411536 OMIM:300661 ORPHA:411543 OMIM:268310 OMIM:613848 ORPHA:798 OMIM:222900 OMIM:222730 ORPHA:94088 OMIM:220150 OMIM:167030 OMIM:612076 ORPHA:157215 OMIM:612286 ORPHA:60025 OMIM:241530 OMIM:138500 ORPHA:79259 OMIM:232220 OMIM:220100 OMIM:179800 ORPHA:35710 ORPHA:137605 ORPHA:93160 OMIM:278300
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.